Keith J. August, MD, MS

Section Chief, Oncology, Hematology/Oncology/BMT; Director, Leukemia & Lymphoma Program, Hematology, Oncology & Bone Marrow Transplant; Associate Director, Experimental Therapeutics in Pediatric Cancer Program, Hematology/Oncology/BMT; Professor of Pediatrics, University of Missouri-Kansas City School of Medicine; Clinical Assistant Professor of Pediatrics, University of Kansas School of Medicine

Full Biography

Keith August, MD, MS, Oncology Section Chief, Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation (BMT), received a 2024 Hyundai Hope on Wheels Impact Grant. The one-year, $100,000 award will continue to help support the salaries of two regulatory cancer research coordinators for Oncology, Experimental Therapeutics and BMT at Children's Mercy Kansas City.

Last year, Dr. August received an impact grant from Hyundai Hope on Wheels to provide salary support for the regulatory cancer research coordinators. The coordinators focus on meeting the standards of regulatory compliance for research trials and studies, and they currently provide support to more than 50 clinical trials at Children’s Mercy.

“This support from the Hyundai Hope on Wheels grant is critical to maintain our clinical trials infrastructure,” said Dr. August. “The treatment of pediatric cancer has improved dramatically in recent years, and we are committed to making sure children and young adults have access to novel therapies here at Children’s Mercy Kansas City.”

Hyundai Hope on Wheels awards grants to researchers at member institutions of the Children’s Oncology Group (COG), a National Cancer Institute supported clinical trials group. The Impact Grant provides funding for programmatic initiatives in pediatric oncology research and clinical care.